CARESIDE Submits Direct Bilirubin Test for FDA Clearance Test Aiding in Diagnosis and Treatment of Liver Diseases including Hepatitis Will Make CARESIDE Analyzer(tm); First Diagnostic Device Providing Rapid Direct Bilirubin Result CULVER CITY, Calif.,...

CARESIDE Reports Third Quarter Results Company Rapidly Approaches December Launch of Blood-Testing System; Sales, Operational and Production Infrastructure is In Place; Test Menu has Expanded with Additional FDA Test Approvals CULVER...

CARESIDE On Schedule with FDA Point-of-Care Marketing Submission CULVER CITY, Calif. November 2, 1999 (PRIMEZONE) -- CARESIDE, Inc. (AMEX:CSA) (AMEX:CSA.W) announced its filing of a premarket notification to the U.S. Food and Drug Administration (FDA) to add the...

Careside Submits CO2 Test for FDA Clearance CULVER CITY, Calif., Aug. 11, 1999 (PRIMEZONE) -- CARESIDE, Inc. (AMEX:CSA) announced submission of its CARESIDE(TM) CO2 blood test to the U.S. Food and Drug Administration (FDA). The test is...

Careside Receives FDA Clearance for Its Coagulation Blood Test CULVER CITY, Calif, August 9, 1999, (PRIMEZONE) -- CARESIDE, Inc. (AMEX:CSA) today announced clearance of its coagulation test CARESIDE(TM) PT by the U.S. Food and Drug Administration (FDA), bringing...